Retinal ischemic preconditioning in the rat: Requirement for adenosine and repetitive induction

Investigative Ophthalmology and Visual Science

Volumn 40, Issue 6, 1999, Pages 1200-1216

  Li, Bing ^a   Roth, Steven ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2 RECEPTOR; ADENOSINE DERIVATIVE; ADENOSINE RECEPTOR STIMULATING AGENT; CYCLODEXTRIN;

ARTICLE; CONCENTRATION (PARAMETERS); DRUG MECHANISM; ELECTRORETINOGRAM; INTRAVITREAL DRUG ADMINISTRATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; RETINA BLOOD FLOW; RETINA ISCHEMIA;

ADENOSINE; ANIMALS; ISCHEMIC PRECONDITIONING; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PURINERGIC P1; RETINAL VESSELS; XANTHINES;

EID: 0032948102     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Kirino T, Tsujita Y, Tamura A. Induced tolerance to ischemia in gerbil hippocampal neurons. J Cereb Blood Flow Metab. 1991;11: 299-307.
2. Martin HB, Walter CL. Preconditioning: an endogenous defense against the insult of myocardial ischemia. Anesth Analg. 1996;83: 639-645.
3. Chen J, Simon R. Ischemic tolerance in the brain. Neurology. 1997;48:306-311.
4. Roth S, Li B, Rosenbaum PS, Gupta H, Goldstein IM, Maxwell KM, Gidday JM. Preconditioning completely prevents injury after retinal ischemia in rats. Invest Ophthalmol Vis Sci. 1998;39:775-785.
5. Tomai F, Crea F, Gaspardone A, Versaci F, Ghini AS, DePaulis R, Chiariello L, Gioffre PA. Phentolamine prevents adaptation to ischemia during coronary angioplasty: role of alpha-adrenergic receptors in ischemic preconditioning. Circulation. 1997;96:2171-2177.
6. Parratt JR, Szekeres L. Delayed protection of the heart against ischaemia. Trends Pharmacol Sci. 1995;16:351-355.
7. Liang BT, Jacobson KA. A physiological role of the adenosine A3 receptor: sustained cardioprotection. Proc Natl Acad Sci USA. 1998;95:6995-6999.
8. + channels in cerebral ischemic preconditioning. Proc Natl Acad Sci USA. 1995;:92:4666-4670.
9. Perez-Pinzon MA, Mumford PL, Rosenthal M, Sick TJ. Anoxic preconditioning in hippocampal slices: Role of adenosine. Neuroscience. 1996;75:687-694.
10. Kvanta A, Seregard S, Sejersen S, Kull B, Fredholm BB. Localization of adenosine receptor messenger RNAs in the rat eye. Exp Eye Res. 1997;65:595-602.
11. Roth S, Rosenbaum PS, Osinski J, et al. Ischemia induces significant changes in purine concentration in the retina-choroid in rats. Exp Eye Res. 1997;65:771-779.
12. Roth S, Park SS, Sikorski C, Osinski J, Chan R. Purine nucleoside concentration during reperfusion following retinal ischemia in rats. Curr Eye Res. 1997;16:875-885.
13. Ostwald P, Park SS, Toledano AY, Roth S. Adenosine receptor blockade and nitric oxide synthase inhibition: impact upon blood flow and the electroretinogram following retinal ischemia. Vision Res. 1997;37:3453-3461.
14. Gidday JM, Park TS. Microcirculatory responses to adenosine in the newborn pig retina. Pediatr Res. 1993;33:620-627.
15. Larsen AK, Osborne NN. Involvement of adenosine in retinal ischemia: Studies in the rat. Invest Ophthalmol Vis Sci. 1996;37: 2603-2611.
16. Roth S, Osinski J, Park SS, Ostwald P, Moshfeghi AA. Measurement of purine nucleoside concentration in the intact rat retina. J Neurosci Methods. 1996;68:87-90.
17. von Lubitz DJ, Lin RCS, Jacobson KA. Cerebral ischemia in gerbils: effects of acute and chronic treatment with adenosine A2a receptor agonist and antagonist. Eur J Pharmacol. 1995;287:295-302.
18. Phillis JW. The effects of selective Al and A2a adenosine receptor antagonists on cerebral ischemic injury in the gerbil. Brain Res. 1995;705:79-84.
19. Bisserbe JC, Pascal O, Deckert J, Maziere B. Potential use of DPCPX as a probe for in vivo localization of brain A1 receptors. Brain Res. 1992;599:6-12.
20. Jacobson KA, Galen PJV, Williams M. Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential. J Med Chem. 1992;35:407-422.
21. 6-sulfoalkyl derivatives of adenosine: water-soluble and peripherally selective adenosine agonists. J Med Chem. 1992;35:4143-4149.
22. Siddiqi SM, Jacobson KA, Esker JL, et al. Search for new purine- and ribose-modined adenosine analogues as selective agonists and antagonists at adenosine receptors. J Med Chem. 1995;38:1174-1188.
23. von Lubitz DKJE, Beenhakker M, Lin RC-S, et al. Reduction of postischemic brain damage and memory deficits following treatment with the selective adenosine A1 receptor agonist. Eur J Pharmacol. 1996;302:43-48.
24. Armstrong S, Ganote CE. Adenosine receptor specificity in preconditioning of isolated rabbit cardiomyocytes: evidence of A3 receptor involvement. Cardiovasc Res. 1994;28:1049-1056.
25. Roth S. Post-ischemic hyperemia in the retina: the effects of adenosine receptor blockade. Curr Eye Res. 1995;14:323-328.
26. Gidday JM, Park TS. Adenosine-mediated autoregulation of retinal arteriolar tone in the piglet. Invest Ophthalmol Vis Sci. 1993;34: 2713-2719.
27. Li B, Rosenbaum PS, Jennings NM, Maxwell KM, Roth S. Differential roles of adenosine receptor subtypes in retinal ischemia-reperfusion injury in the rat. Exp Eye Res. 1999;68:9-17.
28. Coates J, Sheehan MJ, Strong P. 1,3-Dipropyl-8-cyclopentyl xanthine (DPCPX): a useful tool for pharmacologists and physiologists. Gen Pharmacol. 1994;25:387-394.
29. Jacobson KA, Nikodijevic O, Padgett WL, Gallo-Rodriquez C, Maillard M, Daly JW, 8-(3-Chlorostyryl)caffeine (CSC) is a selective A2-adenosine antagonist in vitro and in vivo. FEBS Lett. 1993;323: 141-144.
30. Ongini E, Fredholm BB. Pharmacology of adenosine A2a receptors (review). Trends Pharmacol Sci. 1996;17:364-372.
31. Ishida T, Yarimizu K, Gute DG, Korthuis RJ. Mechanisms of ischemic preconditioning. Shock. 1997;8:86-94.
32. Rudolphi KA, Schubert P. Modulation of neuronal and glial cell function by adenosine and neuroprotection in vascular dementia. Behav Brain Res. 1997;83:123-128.
33. Sweeny MI. Neuroprotective effects of adenosine in cerebral ischemia: window of opportunity. Neurosci Behav Rev. 1997;21:207-217.
34. Latini S, Corsi C, Pedata F, Pepeu G. The source of brain adenosine outflow during ischemia and electrical stimulation. Neurochem Intl. 1996;28:113-118.
35. Choi DW. Calcium: still center-stage in hypoxic-ischemic neuronal death. Trends Neurosci. 1995;18:58-60.
36. Cronstein B. Adenosine, an endogenous anti-inflammatory agent (review). J Appl Physiol. 1994;76:5-13.
37. Sydserff SG, Borelli AR, Palmer GC, Cross AJ. Ischaemic tolerance is blocked by NMDA antagonism. Soc Neurosci Abstracts. 1998; 24:87.7.
38. Zhu Y, Gidday JM. Hypoglycemic hyperemia in retina of newborn pigs. Involvement of adenosine. Invest Ophthalmol Vis Sci. 1996; 37:86-92.
39. Jerome SN, Akimitsu T, Gute DC, Korthuis RJ. Ischemic preconditioning attenuates capillary no-reflow induced by prolonged ischemia and reperfusion. Am J Physiol. 1995;268:H2063-H2067.
40. Hughes WF. Quantitation of ischemic damage in the rat retina. Exp Eye Res. 1991;53:573-582.
41. Blazynski C, Cohen AI, Fruh B, Niemeyer G. Adenosine: autoradiographic localization and electrophysiologic effects in the cat retina. Invest Ophthalmol Vis Sci. 1989;30:2533-2536.
42. Braas KM, Zarbin MA, Snyder SH. Endogenous adenosine and adenosine receptors localized to ganglion cells of the retina. Proc Natl Acad Sci USA. 1987;84:3906-3910.
43. Blazynski C. Discrete distributions of adenosine receptors in mammalian retina. J Neurochem, 1990;54:648-655.
44. Kato H, Kogure K, Nakano S. Neuronal damage following repeated brief ischemia in the gerbil. Brain Res. 1989;479:366-370.
45. Chen T, Kato H, Liu X-H, Araki T, Itoyama Y, Kogure K. Ischemic tolerance can be induced repeatedly in the gerbil hippocampal neurons. Neurosci Lett. 1994;177:159-161.
46. Hakim AM. Could transient ischemic attacks have a cerebroprotective role? Stroke. 1994;25:715-717.